A novel oral therapy that inhibits the interleukin-23 inflammatory pathway provided control of moderate-to-severe psoriasis at a level similar to a biologic.
Medscape Medical News
Source link : https://www.medscape.com/viewarticle/moderate-severe-psoriasis-novel-oral-therapy-acts-biologic-2025a1000vbh?src=rss
Author :
Publish date : 2025-11-12 14:24:00
Copyright for syndicated content belongs to the linked Source.
